Anesthesia Drugs: Worldwide Markets

Published by: Kalorama Information

Published: Jul. 1, 2007 - 156 Pages

Table of Contents

• Introduction
  
• Scope and Methodology
  
• Size and Growth of the Market
  
• Issues and Trends Affecting Market
  
• Leading Competitors

Chapter Two: Introduction The World Anesthesia

• Drug Market
  
  • Introduction and History to Anesthesia Drugs
    
  • Types of Anesthesia
    
  • General Anesthesia
    
  • Local Anesthesia
    
  • Adjunctive Therapies in Anesthesia
    
  • Routes of Administration
    
  • Inhalation
    
  • Mask Inhalation
    
  • Laryngeal Mask
    
  • Endotracheal Administration
    
  • Controlled Respiration
    
  • Intravenous
    
  • Topical Application
    
  • Transdermal/Transmucosal Application
  
  
  
• Distribution Channels
  
• Demographics and Statistics
  
• Worldwide Demographics
  
• Procedures by Type
  
• Complications in Anesthesia

Chapter Three: General Anesthesia

• Overview
  
  • Induction of General Anesthesia
    
  • Preoxygenation
    
  • Loss of Consciousness
  
  
  
• Description of Products
  
  • Diprivan
    
  • Ultane/Sevorane
    
  • Ethrane
    
  • Forane
    
  • Pentothal
    
  • Suprane
    
  • Ketalar
    
  • Brevital
  
  
  
• Generic Drug Impact and Availability
  
• Research and Development
  
  • Aquavan
    
  • Propofol IDD-D
    
  • Market Size and Growth
    
  • Competitive Analysis

Chapter Four: Local Anesthesia

• Overview
  
  • Techniques of Administration
    
  • Topical Application
    
  • Transdermal/Transmucosal
    
  • Simple Local Infiltration
    
  • Regional Injections
    
  • Spinal and Epidural Anesthesia
    
  • Intrathecal Block
    
  • Epidural, Peridural Block
  
  
  
• Description of Products
  
  • AminoAmides
    
  • Xylocaine/LidoSite/Lidoderm/Dentipatch
    
  • Carbocaine/Isocaine/Polocaine
    
  • Marcaine/Sensorcaine
    
  • Citanest
    
  • Naropin
    
  • Septocaine
    
  • Amino Esters
    
  • Novocaine
    
  • Cetacaine/Pontocaine
    
  • Nesacaine
    
  • Cocaine Hydrochloride
    
  • Strocain /Mucaine
    
  • Combinations
    
  • Synera/Pliaglis
    
  • EMLA
    
  • Duocaine
    
  • Exactacain
  
  
  
• Generic Drug Impact and Availability
  
• Research and Development
  
• Market Size and Growth
  
• Competitive Analysis

Chapter Five: Adjunctive Therapies in Anesthesia

• Overview
  
  • Description of Products
    
  • Neuromuscular Blocking Agents
    
  • Preanesthetic Sedation and Anesthesia Maintenance
    
  • Anesthesia Reversal Agents
    
  • Generic Drug Impact and Availability
    
  • Research and Development
    
  • Market Size and Growth
    
  • Competitive Analysis

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

• Total Market Size and Forecast
  
  • Competitor Analysis

Chapter Seven: Issues and Trends

• Anesthesia Drug Market
  
• Introduction
  
• Regulation of Anesthesia Drugs
  
• Dentistry and Anesthesia
  
• Anesthesia and Complications in Pediatric Applications
  
• Anesthesia and the Benefits to Depression Patients
  
• Anesthesia and Sleep
  
• Gender Differences in Anesthesia Reaction
  
• Trends in Conscious Sedation

Chapter Eight: Corporate Profiles

• Introduction
  
  • Abbott Laboratories
    
  • Abraxis BioScience, Inc
    
  • Anesiva, Inc.
    
  • Baxter International, Inc.
    
  • B. Braun Melsungen AG
    
  • Dentsply International, Inc.
    
  • Endo Pharmaceuticals Holdings, Inc
    
  • Hospira, Inc.
    
  • MGI Pharma, Inc.
    
  • Minrad International, Inc.
    
  • Organon N.V.
    
  • Roche.
    
  • SkyePharma plc
    
  • TEVA

Appendix: Anesthesia List of Companies

table of exhibits

Chapter One: Executive Summary

• Table 1-1: The Market for Anesthesia Drugs 2004-2011
  
• Figure 1-1: The Market for Anesthesia Drugs 2004-2011

Chapter Two: Introduction: The World Anesthesia  Drug Market

• Table 2-1: World Population by Selected Geographical Region, 2006-2050
  
• Figure 2-1: World Population by Selected Geographical Region, 2006-2050
  
• Table 2-2: Estimated World Population by Age and Geographical Region, 2006
  
• Table 2-2: Estimated World Population by Age and Geographical Region, 2006
  
• Table 2-3: Procedures by Type, 2006
  
• Figure 2-3: Procedures by Type Worldwide, 2006
  
• Figure 2-4: Procedures by Type U.S., 2006
  
• Table 2-4: Worldwide Anesthesia Complications and Related Mortality
  
• Figure 2-5: Worldwide Anesthesia Complications and Related Mortality

Chapter Three: General Anesthesia

• Table 3-1: Marketed Brands for General Anesthesia Drugs  (Type, Brand, and Manufacturer)  
  
• Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
  
• Figure 3-1: Brand vs. Generic General Anesthetic Market 2004-2006
  
• Table 3-3: General Anesthesia Drugs in Development
  
• Table 3-4: The Market for General Anesthesia Drugs 2004-2011
  
• Figure 3-2: The Market for General Anesthesia Drugs 2004-2011
  
• Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Inhalation, Parenteral and Rectal, Total)   
  
• Figure 3-3: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2006  (Inhalation, Parenteral and Rectal, Total)
  
• Table 3-6: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
  
• Figure 3-4: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)     
  
• Table 3-7: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
  
• Figure 3-5: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006

Chapter Four: Local Anesthesia

• Table 4-1: Selected Marketed Local Anesthesia Drugs  (Type, Brand, and Manufacturer)        
  
• Table 4-2: Selected Generic Drug Manufacturers and Products for Local
  Anesthesia
  
• Figure 4-1: Brand vs. Generic Local Anesthetic Market 2004-2006
  
• Table 4-3: Local Anesthesia Drugs in Development
  
• Table 4-4: The Market for Local Anesthesia Drugs 2004-2011
  
• Figure 4-2: The Market for Local Anesthesia Drugs 2004-2011
  
• Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
  
• Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery
  Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
  
• Table 4-6: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World) 
  
• Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
  
• Table 4-7: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
  
• Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006   

Chapter Five: Adjunctive Therapies in Anesthesia

• Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia  (Type, Brand,
  and Manufacturer)
  
• Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
  
• Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market
   2004-2006
  
• Table 5-3: Adjunctive Therapies in Anesthesia in Development
  
• Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2004-2011
  
• Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2004-2011
  
• Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products
  Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
  
• Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share
  by Geographic Region, 2006 (U.S., E.U., Rest of World)
  
• Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated
  Revenues and Market Share of Leading Suppliers 2006
  
• Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2006

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

• Table 6-1: The Market for Anesthesia Drugs 2004-2011
  
• Figure 6-1: The Market for Anesthesia Drugs 2004-2011
  
• Table 6-2: Anesthesia Drug Market by Type  2004-2011
  
• Figure 6-2: Anesthesia Drug Market by Type  2004-2011
  
• Figure 6-3: Anesthesia Drug Market by Type  2006 (General, Local, Adjunctive Anesthesia)
  
• Figure 6-4: Anesthesia Drug Market by Type  2011
  
• Table 6-3: Leading Suppliers Anesthesia Revenues and Significant Segments
  of Participation, 2006 (General, Local, Adjunctive)

Abstract

This Kalorama Information report - Anesthesia Drugs: Worldwide Markets - focuses on three primary segments of anesthesia:

• General Anesthesia (Inhalation, Parenteral and Rectal)
• Local Anesthesia (Topical, Transdermal, Parenteral)
• Adjunctive Therapies in Anesthesia

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The issues and trends addressed in the anesthesia drug market include:

• Regulation of Anesthesia Drugs
• Dentistry and Anesthesia
• Anesthesia and Pediatric Applications
• Anesthesia and Benefits to Depressed Patients
• Anesthesia and Sleep
• Gender Differences in Anesthesia Reaction
• Trends in Conscious Sedation

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

As part of its market coverage, the following companies were profiled in this report:

• Abbott Laboratories
• Abraxis BioScience, Inc.
• Anesiva, Inc.
• Baxter International, Inc
• B. Braun Melsungen AG
• Dentsply International, Inc.
• Endo Pharmaceuticals Holdings, Inc.
• Hospira, Inc.
• MGI Pharma, Inc
• Minrad International, Inc.
• Organon N.V.
• Roche
• SkyePharma plc
• TEVA

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.